Logo image of IBG.CA

IBI Group Inc (IBG.CA) Stock Fundamental Analysis

TSX:IBG - Toronto Stock Exchange - CA44925L1031 - Common Stock - Currency: CAD

19.48  -0.01 (-0.05%)

Fundamental Rating

2

IBG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 6 industry peers in the Professional Services industry. IBG has a bad profitability rating. Also its financial health evaluation is rather negative. IBG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IBG was profitable.
IBG.CA Yearly Net Income VS EBIT VS OCF VS FCFIBG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 6.63%
ROE 28.61%
ROIC 16.53%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG.CA Yearly ROA, ROE, ROICIBG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 50 100

1.3 Margins

The Operating Margin and Gross Margin are not available for IBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 5.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBG.CA Yearly Profit, Operating, Gross MarginsIBG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBG is creating value.
IBG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, IBG has an improved debt to assets ratio.
IBG.CA Yearly Shares OutstandingIBG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
IBG.CA Yearly Total Debt VS Total AssetsIBG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

IBG has an Altman-Z score of 2.59. This is not the best score and indicates that IBG is in the grey zone with still only limited risk for bankruptcy at the moment.
IBG has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACC2.39
WACC6.91%
IBG.CA Yearly LT Debt VS Equity VS FCFIBG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M 150M

2.3 Liquidity

IBG has a Current Ratio of 1.79. This is a normal value and indicates that IBG is financially healthy and should not expect problems in meeting its short term obligations.
IBG has a Quick Ratio of 1.79. This is a normal value and indicates that IBG is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.79
IBG.CA Yearly Current Assets VS Current LiabilitesIBG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

IBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.00%, which is quite impressive.
The Earnings Per Share has been growing by 75.18% on average over the past years. This is a very strong growth
The Revenue has grown by 12.12% in the past year. This is quite good.
Measured over the past years, IBG shows a small growth in Revenue. The Revenue has been growing by 4.65% on average per year.
EPS 1Y (TTM)56%
EPS 3Y15.35%
EPS 5Y75.18%
EPS Q2Q%9.09%
Revenue 1Y (TTM)12.12%
Revenue growth 3Y6.47%
Revenue growth 5Y4.65%
Sales Q2Q%11.59%

3.2 Future

Based on estimates for the next years, IBG will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.01% on average per year.
Based on estimates for the next years, IBG will show a small growth in Revenue. The Revenue will grow by 6.60% on average per year.
EPS Next Y30.59%
EPS Next 2Y20.68%
EPS Next 3Y18.7%
EPS Next 5Y18.01%
Revenue Next Year8.97%
Revenue Next 2Y6.86%
Revenue Next 3Y6.51%
Revenue Next 5Y6.6%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBG.CA Yearly Revenue VS EstimatesIBG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
IBG.CA Yearly EPS VS EstimatesIBG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.97, which indicates a rather expensive current valuation of IBG.
IBG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.45.
The Price/Forward Earnings ratio is 20.27, which indicates a rather expensive current valuation of IBG.
IBG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.97
Fwd PE 20.27
IBG.CA Price Earnings VS Forward Price EarningsIBG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.36
IBG.CA Per share dataIBG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBG's earnings are expected to grow with 18.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.82
PEG (5Y)0.33
EPS Next 2Y20.68%
EPS Next 3Y18.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IBG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBI Group Inc

TSX:IBG (9/28/2022, 7:00:00 PM)

19.48

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap607.99M
Analysts80
Price Target19.76 (1.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.97
Fwd PE 20.27
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 7.02
P/tB N/A
EV/EBITDA 9.36
EPS(TTM)0.78
EY4%
EPS(NY)0.96
Fwd EY4.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS15.04
BVpS2.78
TBVpSN/A
PEG (NY)0.82
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 6.63%
ROE 28.61%
ROCE N/A
ROIC 16.53%
ROICexc N/A
ROICexgc 19.26%
OM N/A
PM (TTM) 5.28%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.79
Altman-Z 2.59
F-Score7
WACC6.91%
ROIC/WACC2.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56%
EPS 3Y15.35%
EPS 5Y75.18%
EPS Q2Q%9.09%
EPS Next Y30.59%
EPS Next 2Y20.68%
EPS Next 3Y18.7%
EPS Next 5Y18.01%
Revenue 1Y (TTM)12.12%
Revenue growth 3Y6.47%
Revenue growth 5Y4.65%
Sales Q2Q%11.59%
Revenue Next Year8.97%
Revenue Next 2Y6.86%
Revenue Next 3Y6.51%
Revenue Next 5Y6.6%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A